DOYEN ELEMENTS INC.’S Stock Subscription Offering Now OPEN

September 12, 2017

Dear Investors,

DOYEN ELEMENT, INC. can now sell to both accredited and non-accredited investors shares of its stock, offering Seven Million (7M) shares at Seven US Dollars ($7.00) per share under the effective registration.

Please use promo code YES INTL in the section of the offering agreement upon submitting your subscription agreement; http://www.doyenelements.com/invest/ provides the necessary information to proceed forward with the stock subscription offering in becoming a shareholder in DOYEN.

DOYEN’s unique and novel business model provides ALL services as they pertain to the medical cannabis industry everything from building space to distribution. The Company is NOT directly involved in the actual growing of cannabis but provides a turn-key solution to producers. These solutions enable the Company to generate revenues and to grow its footprint in the medical cannabis space in Colorado, USA.

If you have any questions on the sale of shares registered under the Regulation A, Tier II offering, please contact us with any and all questions, regarding this 7M at $7.00 per share offering, rich@yesinternational.com, 757-306-6090.

With Warmest Regards,

/s/

Rich Kaiser
Investor Relations- DOYEN ELEMENTS, INC.
www.doyenelements.com
rich@yesinternational.com
757-306-6090

Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that Doyen Elements, Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.

PREDICTIVE TECHNOLOGY GROUP, INC. (PRED) EVALUATES UP-LISTING TRADING STATUS TO OTCQB

Salt Lake City, UT- September 11, 2017- Predictive Technology Group, Inc. (OTCPINK: PRED) proceeds with the evaluation of moving the Company’s trading status to OTCQB on OTC MARKETS.

Management determined the “NEW” Alternative Listing Standards which became available to issuers could be prudent, saving time and cost effective objective to uplift PRED’s tradable shares.

Effective May 18, 2017, the OTC Markets amended its rules for the OTCQB qualification which allows the issuers that follow “Alternative Reporting Standard.”  The new standard for OTCQB for alternative reporters now allows a company to file 1-year audited financial reports.  These reports are to US GAAP standards through a PCAOB qualified auditor.   A company must still maintain a bid price of $0.01 per shares, needs a board of directors with at least two independent directors, and an audit committee comprised of a majority of independent directors.

OTC MARKETS believes these updated rules for OTCQB provides non-SEC Reporting companies with the benefits of public trading while lowering the cost and complexity of being public. The new market standards give “Alternative Reporting” companies an efficient way to raise their profile among the investor and broker dealer communities, access greater liquidity, and trade on a SEC-recognized market. Thus, removing the trading restrictions placed on “Pink” market securities.

Based on these news standards, PRED’s management remains confident that uplifting to the OTCQB can be done timely. Once management and the board at PRED finish their due diligence on OTC MARKETS’ “ALTERNATIVE REPORTING STANDARDS,” expect more news to follow.

Management continues on its fiduciary path with a primary objective of creating shareholder value.

About Predictive Technology Group, Inc.:

Predictive Technology Group, Inc. (OTCPINK:PRED), through its wholly owned subsidiaries, revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company develops and acquires proprietary technologies that open windows into the origin of human disease and the role that genes and their related proteins play in diseases’ onsets and progressions. PRED’s subsidiaries use gene-based information as cornerstones in the development of new diagnostics that assess a person’s risk of disease and therapeutic products effectively designed to prevent and treat diseases.

For further information about PRED and this release contact Rich Kaiser, Investor Relations, YES INTERNATIONAL, 757-306-6090 and yes@yesinternational.com, www.predictivetechnologygroup.com.

 

Forward-Looking Statements

To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new vaccines and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment and other risks the Company may identify from time to time in the future.

 

Contact

Rich Kaiser

YES INTERNATIONAL

757-306-6090

yes@yesinternational.com

www.predictivetechnologygroup.com

www.predbiotech.com

www.predrx.com

 

DOYEN ELEMENTS INC.’S USSEC REGISTRATION EFFECTIVE, PROCEEDING WITH SALE OF 7 MILLION SHARES

September 2, 2017

Dear Investors,

The United States Securities and Exchange Commission (USSEC) as of yesterday, Friday, September 1, 2017, informed DOYEN ELEMENTS, INC.’s (DOYEN) management that its Regulation A, Tier II, Registration Statement became effective.

The effectiveness now allows DOYEN to sell to both accredited and non-accredited investors shares of its stock, offering Seven Million (7M) shares at Seven US Dollars ($7.00) per share under the effective registration.

DOYEN’s unique and novel business model provides ALL services as they pertain to the medical cannabis industry, everything from building space to distribution. The Company is NOT directly involved in the actual growing of cannabis but provides a turn-key solution to producers. These solutions enable the Company to generate revenues and to grow its foot print in the medical cannabis space, not only in Colorado but soon in other states permitting medical marijuana.

NOW with the USSEC approval, the Company can attract investors into this novel idea of providing ‘A-Z’ services in the medical cannabis industry space.

DOYN received numerous news reports regarding its business fundamentals in the cannabis medical space in Colorado, USA. These reports, social media postings/interactions, and direct contacts created a “BUZZ” within the domestic and international investment communities who expressed interest in becoming shareholders. Such a “BUZZ” can sometimes create enormous demand and interest in this type of share registration.

Management hired CROWDFUNDX who is leading the digital and paid marketing campaign to drive investor awareness for the offering. Management’s objective to fully sell-out the 7M share offering for an aggregate value of $49 Million US Dollars, and then proceed with this “crowd financed” IPO to hopefully list on a major stock exchange in the near future.

During the week of September 3, 2017, interested parties can expect the opening of the registered sales for those who might like to participate in the 7M share offer (second email to follow on “OPENING”).

This historical event for the operations at DOYEN ELEMENTS, INC. could be an enormous opportunity for ALL involved, if you have any questions on the sale of shares registered under the Regulation A, Tier II offering, please contact us with any and all questions regarding this 7M at $7.00 per share offering, YES INTERNATIONAL, 757-306-6090.

Contacts for DOYEN ELEMENTS, INC.:

Rich Kaiser
YES INTERNATIONAL
Investor Relations- DOYEN ELEMENTS, INC.
www.yesinternational.com
rich@yesinternational.com
757-306-6090

Darren Marble
CROWD FUND X
www.crowdfundx.io
darren@crowdfundx.io
310-710-9920

Olivia Mannix
CANNABRAND
Media Relations-DOYEN ELEMENTS, INC.
www.cannabrand.uc
olivia@cannabrand.us
303-223-7411

DOYEN ELEMENTS, INC.
Info@doyenelements.com
www.doyenelements.com
800-511-5925

Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that Doyen Elements, Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.